(Q40703644)

22 September 2017

title

Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg (English)

1 reference

22 September 2017

7

Osterhaus AD

1 reference

22 September 2017

Heijtink RA

1

1 reference

22 September 2017

van Bergen P

2

1 reference

22 September 2017

van Roosmalen MH

3

1 reference

22 September 2017

Sünnen CM

4

1 reference

22 September 2017

Paulij WP

5

1 reference

22 September 2017

Schalm SW

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

22 September 2017

1 reference

22 September 2017

volume

19

1 reference

22 September 2017

issue

27

1 reference

22 September 2017

page(s)

3671-3680

1 reference

The clinical significance of surface antigen variants of hepatitis B virus

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Epitope mapping and serodiagnosis using Ata- and (Lys)7 peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Purification and biophysical characterization of hepatitis B antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Characterization of small hepatitis B surface antigen epitopes involved in binding to human annexin V

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Identification of polyclonal serum specificities with phage-display libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Mapping of linear B-cell epitopes of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Evidence for the denaturation of recombinant hepatitis B surface antigen on aluminium hydroxide gel

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Antibody responses to recombinant and plasma derived hepatitis B vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

Vaccine-induced escape mutant of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900082-2

7 January 2021

10.1016/S0264-410X(01)00082-2

Identifiers

DOI

1 reference

22 September 2017

1 reference